Evaluation of the effect of Mutramargata Uttararabasti(Intravesical Drug Administration) with Shudhha Bala Taila on the Quality of Life of Cystocele patients
Phase 2
Completed
- Conditions
- Health Condition 1: N811- Cystocele
- Registration Number
- CTRI/2022/01/039573
- Lead Sponsor
- All India Institute of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1.Patients having clinical symptoms of cystocele
2.Patients diagnosed with grade I and grade II
cystocele with or without urethrocele
3.Patients willing to participate in the study and
willing to give written consent.
Exclusion Criteria
1.Patients with severe systemic disorders
2.Pregnant females
3.Patients having malignancy
4.Patients having third degree uterine prolapse
(Procidentia)
5.Known cases of sexually transmitted diseases and
acute UTI
6.Uttarabasti Anarha
7.Patients with urethral stricture
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Improvement in the Quality of Life of Cystocele patients through P-QOL Status. <br/ ><br>2.Improvement in the clinical Symptoms of Cystocele.Timepoint: 0th Day, 7th Day, 22nd Day
- Secondary Outcome Measures
Name Time Method 1.Reduction in the scores of UDI- 6, IIQ-7, POPDI-6 scales. <br/ ><br>2.Improvement in Pelvic Organ Prolapse Quantification grading scale. <br/ ><br>3.Finding a possible correlation of Cystocele in Ayurveda. <br/ ><br>Timepoint: 0th Day, 7th Day, 22nd Day